SeaPlanner Tackles Weather Downtime with ForeCoast Marine

SeaRoc Group has announced the integration of metocean risk management software – ForeCoast® Marine – with its SeaPlanner™ marine management tool.

Through the integration of ForeCoast Marine, the SeaPlanner system will provide a metocean risk management feature for accessing and viewing metocean data from various sources. It will optimise the timing and sequencing of operations to minimise weather downtime, for quantifying the knock-on effects of metocean delays, and for generating simple and informative reports that can be shared with the supply chain in just a few clicks, SeaRoc said.

“The integration of ForeCoast® Marine enables a completely new function to the existing planning features of the SeaPlanner system,” said Steve Pears, Managing Director at SeaRoc Group.

“Not only can clients effectively manage their transfer plans with vessel availability, records of tasks to be carried out and availability of trained personnel, but with the ForeCoast® Marine integration it is now possible to include availability of weather and metocean windows for the transits to take place – potentially saving thousands and ensuring operational optimisation at all times. This additional functionality allows SeaPlanner clients to plan all types of vessel activity, taking into consideration, weather and metocean forecasts.”

SeaPlanner provides personnel and operational planning tools for large-scale projects. The software features a range of tools including inductions, certification management, personnel and asset tracking, manifesting and access control. New for 2018 are RAMS and Permit to Work functionality which provide a complete audit trail of the contractor’s journey throughout the project.

‘‘Weather downtime costs many millions of pounds during the construction of a windfarm, and during the life of its operations. ForeCoast® Marine helps to reduce these costs through more efficient and informed planning and through a direct reduction in vessel downtime costs,” Dr Mark Lawless, JBA Director said.